Title	Publication Date	Language	Citations
Current Challenges in Cancer Treatment	2016/07/01	English	468
Capecitabine: A review	2005/01/01	English	440
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma	2015/04/01	English	402
Childhood Obesity: A Review of Increased Risk for Physical and Psychological Comorbidities	2013/01/01	English	380
Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation	2015/05/01	English	356
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study	2006/10/01	English	349
Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies	2006/11/01	English	344
Overview of Classical Test Theory and Item Response Theory for the Quantitative Assessment of Items in Developing Patient-Reported Outcomes Measures	2014/05/01	English	327
Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study	2007/07/01	English	281
Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review	2017/11/01	English	272
A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes	2011/01/01	English	271
Lapatinib: A dual inhibitor of human epidermal growth factor receptor tyrosine kinases	2008/08/01	English	261
Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug—naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-group study	2008/08/01	English	260
Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy	2018/06/01	English	259
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia	2007/06/01	English	254
Mechanism of Action of Colchicine in the Treatment of Gout	2014/10/01	English	251
Safety of doxycycline and minocycline: A systematic review	2005/09/01	English	234
The bone quality framework: Determinants of bone strength and their interrelationships, and implications for osteoporosis management	2005/01/01	English	230
Pharmacokinetic Properties of Infliximab in Children and Adults with Crohn's Disease: A Retrospective Analysis of Data from 2 Phase III Clinical Trials	2011/07/01	English	226
Review of Safety and Efficacy of Sleep Medicines in Older Adults	2016/11/01	English	213
Herb and supplement use in the US adult population	2005/11/01	English	212
Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care	2011/06/01	English	209
The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study	2008/04/01	English	207
Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data	2006/10/01	English	207
IBM Watson: How Cognitive Computing Can Be Applied to Big Data Challenges in Life Sciences Research	2016/04/01	English	206
Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers	2006/01/01	English	205
Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly Controlled Type 2 Diabetes	2006/10/01	English	200
Coronary Hypersensitivity Disorder: The Kounis Syndrome	2013/05/01	English	197
Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension	2007/04/01	English	196
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials	2007/01/01	English	196